A Mouse Model of Multiple System Atrophy: Bench to Bedside

Area of Science:

• Neurodegenerative diseases
• Neuropathology
• Animal modeling

Background:

• Multiple system atrophy (MSA) is a rare, aggressive neurodegenerative disorder with unknown causes, challenging diagnosis, and no effective treatments.
• MSA is classified as an alpha-synucleinopathy, characterized by unique oligodendroglial inclusions, distinguishing it from other synucleinopathies like Parkinson's disease.

Purpose of the Study:

• To review the development and utility of experimental models for Multiple System Atrophy (MSA).
• To critically evaluate the advantages and limitations of the PLP-a-syn mouse model in recapitulating human MSA pathology and features.

Main Methods:

• Review of existing in vitro and in vivo models of MSA, including those based on neurotoxicity, alpha-synuclein overexpression, and fibril propagation.
• Specific analysis of the PLP-a-syn mouse model, assessing its ability to mirror key pathological and clinical aspects of human MSA.

Main Results:

• Various MSA models have been developed, reflecting different pathological facets of the disease.
• The PLP-a-syn mouse model successfully replicates motor and non-motor symptoms of human MSA, including striatonigral degeneration and autonomic dysfunction.

Conclusions:

• Experimental models are vital for elucidating MSA pathogenesis and for preclinical therapy screening.
• The PLP-a-syn mouse model offers a valuable tool for advancing MSA research, bridging the gap towards successful clinical trials.